STACY MEUTH: Open Payments
NPI 1891871786 · RICHMOND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,006 in 122 payments from 16 companies in 2025. Trend: 2023 $1,884 · 2024 $2,332 · 2025 $2,006
Food & beverage: $2,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $881 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $286 |
| Janssen Biotech, Inc. | 10 | $224 |
| VIVUS LLC | 6 | $135 |
| Madrigal Pharmaceuticals | 6 | $123 |
| Aimmune Therapeutics, Inc. | 4 | $75 |
| Novo Nordisk Inc | 2 | $48 |
| Ardelyx, Inc. | 2 | $40 |
| Celltrion USA Inc. | 2 | $37 |
| Echosens North America, Inc. | 1 | $31 |
Products named: RINVOQ, XIFAXAN, TREMFYA, SKYRIZI, LINZESS, PANCREAZE, REZDIFFRA, CREON.
Industry payments across TX — which companies pay providers there.
